Jupiter Research Capital (Asia) Ltd’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-24,763
Closed -$6.06M – 729
2026
Q2
$6.06M Buy
+24,763
New +$5.37M 0.68% 26

Other funds holding AXSM

Jupiter Research Capital (Asia) Ltd's AXSM Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd sold out of Axsome Therapeutics (AXSM) in Q3 2026, closing a stake of 24,763 shares — an estimated $6.06M sold.

Jupiter Research Capital (Asia) Ltd first reported a position in AXSM in Q2 2026 and held it in 1 quarter. The position peaked at $6.06M in Q2 2026. 446 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd reported no remaining Axsome Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jupiter Research Capital (Asia) Ltd sold 24,763 Axsome Therapeutics shares in Q3 2026, an estimated $6.06M.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Axsome Therapeutics in Q2 2026 and held it in 1 quarter.
  • Jupiter Research Capital (Asia) Ltd's Axsome Therapeutics position peaked at $6.06M in Q2 2026.
  • 446 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.